These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6337299)
1. Biology of disease. Endogenous control of the neoplastic process. Wheelock EF; Robinson MK Lab Invest; 1983 Feb; 48(2):120-39. PubMed ID: 6337299 [No Abstract] [Full Text] [Related]
2. The chemokine system in cancer biology and therapy. Mantovani A; Savino B; Locati M; Zammataro L; Allavena P; Bonecchi R Cytokine Growth Factor Rev; 2010 Feb; 21(1):27-39. PubMed ID: 20004131 [TBL] [Abstract][Full Text] [Related]
3. Immune responses to tumor antigens and their clinical applications. Balch CM Surgery; 1986 Sep; 100(3):562-71. PubMed ID: 3488601 [No Abstract] [Full Text] [Related]
4. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness. Parthenais E; Haskill S J Immunol; 1979 Sep; 123(3):1334-8. PubMed ID: 313951 [No Abstract] [Full Text] [Related]
5. [Immunological properties of tumor cells that determine the degree of their malignancy]. Lavrovskiĭ VA; Viksler VKh Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110 [No Abstract] [Full Text] [Related]
6. [Immunologic factors in the growth of malignant tumors]. Adolphs HD Med Klin; 1976 Feb; 71(9):353-64. PubMed ID: 768731 [No Abstract] [Full Text] [Related]
7. Resistance of tumor-bearing mice to a second tumor challenge. Gorelik E Cancer Res; 1983 Jan; 43(1):138-45. PubMed ID: 6847762 [No Abstract] [Full Text] [Related]
8. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926 [TBL] [Abstract][Full Text] [Related]
9. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse. Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cells in cancer. Höglund P; Klein E Semin Cancer Biol; 2006 Oct; 16(5):331-2. PubMed ID: 16931040 [No Abstract] [Full Text] [Related]
11. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells. Lotzová E; Savary CA; Stringfellow DA J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603 [TBL] [Abstract][Full Text] [Related]
15. [Morphine affects the proliferation of tumour cells]. Olsen P; Rasmussen M; Stefano GB; Tønnesen EK Ugeskr Laeger; 2004 Nov; 166(48):4347-50. PubMed ID: 15587623 [No Abstract] [Full Text] [Related]
16. Glycosphingolipids as tumor-associated and differentiation markers. Hakomori S; Kannagi R J Natl Cancer Inst; 1983 Aug; 71(2):231-51. PubMed ID: 6576183 [No Abstract] [Full Text] [Related]
17. [Immunology and tumors. Effector cells]. Sebastiani M; Cosma AM; Ferri AM Arch Sci Med (Torino); 1980; 137(2):277-88. PubMed ID: 6971636 [TBL] [Abstract][Full Text] [Related]
18. In vivo models for studies of human tumor metastasis. Hanna N Prog Clin Biol Res; 1982; 89():177-89. PubMed ID: 7111297 [No Abstract] [Full Text] [Related]
19. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages. Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128 [TBL] [Abstract][Full Text] [Related]
20. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Tsutsumi-Miyahara C; Sonoda KH; Egashira K; Ishibashi M; Qiao H; Oshima T; Murata T; Miyazaki M; Charo IF; Hamano S; Ishibashi T Br J Ophthalmol; 2004 Sep; 88(9):1217-22. PubMed ID: 15317719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]